Variant report
Variant | esv3478291 |
---|---|
Chromosome Location | chr7:66858425-66859649 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:66857902..66861234-chr7:66864878..66868630,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185281182 | chr7:66858428-66858429 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34737375 | chr7:66858432-66858433 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs2110004 | chr7:66858450-66858451 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs572463122 | chr7:66858477-66858478 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115256280 | chr7:66858480-66858481 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560999979 | chr7:66858493-66858494 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188326969 | chr7:66858528-66858529 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542193684 | chr7:66858548-66858549 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2110005 | chr7:66858570-66858571 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs2110006 | chr7:66858582-66858583 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs12532409 | chr7:66858597-66858598 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs181104579 | chr7:66858617-66858618 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542984493 | chr7:66858636-66858637 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186461099 | chr7:66858652-66858653 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550636680 | chr7:66858673-66858674 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567441684 | chr7:66858693-66858694 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536210301 | chr7:66858710-66858711 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12534196 | chr7:66858712-66858713 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs58851315 | chr7:66858719-66858720 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs118126393 | chr7:66858731-66858732 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs12532437 | chr7:66858745-66858746 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs575733475 | chr7:66858746-66858747 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79538148 | chr7:66858775-66858776 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554680094 | chr7:66858808-66858809 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs147929055 | chr7:66858809-66858810 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540196892 | chr7:66858817-66858818 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368693073 | chr7:66858829-66858830 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373846819 | chr7:66858831-66858832 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76394683 | chr7:66858851-66858852 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572024879 | chr7:66858854-66858855 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542483840 | chr7:66858857-66858858 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112047333 | chr7:66858877-66858878 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6969421 | chr7:66858881-66858882 | Enhancers Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs386714143 | chr7:66858941-66858942 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs6952460 | chr7:66858942-66858943 | Enhancers Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs547119473 | chr7:66858968-66858969 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183373757 | chr7:66858969-66858970 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115756130 | chr7:66858983-66858984 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139020375 | chr7:66859032-66859033 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558965411 | chr7:66859040-66859041 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569558095 | chr7:66859046-66859047 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12534273 | chr7:66859116-66859117 | Enhancers Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs550012816 | chr7:66859135-66859136 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35621161 | chr7:66859173-66859174 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555212243 | chr7:66859197-66859198 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs74942575 | chr7:66859218-66859219 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12112523 | chr7:66859221-66859222 | Enhancers Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs374447782 | chr7:66859233-66859234 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142862909 | chr7:66859266-66859267 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370621953 | chr7:66859293-66859294 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 20668451 | CNVD |
Prostate cancer | 20601956 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Prostate cancer | 21248069 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Prostate cancer | 17297502 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:66857800-66858600 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
2 | chr7:66857800-66859600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr7:66858000-66858600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr7:66858000-66858800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr7:66858200-66858600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr7:66858200-66858800 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
7 | chr7:66858200-66859400 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr7:66858400-66858800 | Flanking Active TSS | H9 Cell Line | embryonic stem cell |
9 | chr7:66858400-66859200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr7:66858400-66859200 | Enhancers | Colon Smooth Muscle | Colon |
11 | chr7:66858400-66859200 | Enhancers | Fetal Stomach | stomach |
12 | chr7:66858600-66858800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr7:66858600-66858800 | Flanking Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr7:66858800-66859600 | Active TSS | H9 Cell Line | embryonic stem cell |
15 | chr7:66858800-66862800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
16 | chr7:66859600-66859800 | Transcr. at gene 5' and 3' | H9 Cell Line | embryonic stem cell |